fbpx

Hope in treatment for metastatic uveal melanoma

For the first time, a drug has a real positive impact on patients with metastatic uveal melanoma, a disease often qualified as “untreatable.”

 

The good news came from Memorial Sloan-Kettering Cancer Center, whose research results were presented at the 49th annual meeting of the American Society of Clinical Oncology. Researchers found that progression-free survival in patients treated with selumetinib was nearly 16 weeks, and half of these patients experienced tumour shrinkage, with 15% achieving major shrinkage.

 

In comparison, patients treated with temozolomide, the standard chemotherapy, had seven weeks of progression-free survival and no tumour shrinkage. Selumetinib also lengthened overall survival to 10.8 months versus 9.4 months with temozolomide.

 

“This is the first study to show that a systemic therapy provides significant clinical benefit in a randomized fashion to advanced uveal melanoma patients,” said lead author Richard D. Carvajal.

Source: http://www.mskcc.org/pressroom/press/new-therapy-shown-improve-progression-free-survival-and-shrink-tumors-rare-first-time

Featured Posts

Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators

The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools.

Learn More

CORE Publication Helps ECPs Prepare for a New Wave of Dry Eye Disease Medications

Recently Approved and Promising Pharmacological Treatments Spotlighted in Contact Lens Update Issue 77

Read more
The Vision Council logo

New Research Reveals More than One-Third of Eyewear Users Neglect Proper Care

The Vision Council’s Latest Insights Research Report Finds Opportunities to Improve Consumer’s Eyewear Maintenance Habits

Read more

CooperVision Celebrates Earth Day 2024

Thousands of CooperVision employees worldwide are dedicated to improving the way people see each day—and that includes making a positive impact on our planet.

Read more

Ray-Ban and Lenny Kravitz Celebrate the Past, Break Boundaries in the Present Creating a Disruptive Future

Ray-Ban teams up with renowned musician and style icon Lenny Kravitz for the latest Ray-Ban Reverse collection.

Read more

Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators

The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools.

Learn More

CORE Publication Helps ECPs Prepare for a New Wave of Dry Eye Disease Medications

Recently Approved and Promising Pharmacological Treatments Spotlighted in Contact Lens Update Issue 77

Read More
The Vision Council logo

New Research Reveals More than One-Third of Eyewear Users Neglect Proper Care

The Vision Council’s Latest Insights Research Report Finds Opportunities to Improve Consumer’s Eyewear Maintenance Habits

Read More

CooperVision Celebrates Earth Day 2024

Thousands of CooperVision employees worldwide are dedicated to improving the way people see each day—and that includes making a positive impact on our planet.

Read More

Ray-Ban and Lenny Kravitz Celebrate the Past, Break Boundaries in the Present Creating a Disruptive Future

Ray-Ban teams up with renowned musician and style icon Lenny Kravitz for the latest Ray-Ban Reverse collection.

Read More

Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators

The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools.

Learn More

CORE Publication Helps ECPs Prepare for a New Wave of Dry Eye Disease Medications

Recently Approved and Promising Pharmacological Treatments Spotlighted in Contact Lens Update Issue 77

Read more
The Vision Council logo

New Research Reveals More than One-Third of Eyewear Users Neglect Proper Care

The Vision Council’s Latest Insights Research Report Finds Opportunities to Improve Consumer’s Eyewear Maintenance Habits

Read more

CooperVision Celebrates Earth Day 2024

Thousands of CooperVision employees worldwide are dedicated to improving the way people see each day—and that includes making a positive impact on our planet.

Read more

Ray-Ban and Lenny Kravitz Celebrate the Past, Break Boundaries in the Present Creating a Disruptive Future

Ray-Ban teams up with renowned musician and style icon Lenny Kravitz for the latest Ray-Ban Reverse collection.

Read more

Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators

The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools.

Learn More

CORE Publication Helps ECPs Prepare for a New Wave of Dry Eye Disease Medications

Recently Approved and Promising Pharmacological Treatments Spotlighted in Contact Lens Update Issue 77

Read more
The Vision Council logo

New Research Reveals More than One-Third of Eyewear Users Neglect Proper Care

The Vision Council’s Latest Insights Research Report Finds Opportunities to Improve Consumer’s Eyewear Maintenance Habits

Read more

CooperVision Celebrates Earth Day 2024

Thousands of CooperVision employees worldwide are dedicated to improving the way people see each day—and that includes making a positive impact on our planet.

Read more

Ray-Ban and Lenny Kravitz Celebrate the Past, Break Boundaries in the Present Creating a Disruptive Future

Ray-Ban teams up with renowned musician and style icon Lenny Kravitz for the latest Ray-Ban Reverse collection.

Read more